Array Biopharma Inc (NASDAQ:ARRY): Are Hedge Funds Right About This Stock?

Array Biopharma Inc (NASDAQ:ARRY) has experienced a decrease in support from the world’s most elite money managers in recent months.

If you’d ask most stock holders, hedge funds are seen as worthless, old investment tools of years past. While there are over 8000 funds in operation today, we hone in on the aristocrats of this group, close to 450 funds. It is estimated that this group oversees the lion’s share of the smart money’s total capital, and by paying attention to their highest performing investments, we have revealed a number of investment strategies that have historically beaten the broader indices. Our small-cap hedge fund strategy beat the S&P 500 index by 18 percentage points per year for a decade in our back tests, and since we’ve began to sharing our picks with our subscribers at the end of August 2012, we have outperformed the S&P 500 index by 25 percentage points in 6.5 month (explore the details and some picks here).

Array Biopharma Inc (NASDAQ:ARRY)Just as beneficial, bullish insider trading activity is a second way to break down the world of equities. Obviously, there are plenty of incentives for an insider to cut shares of his or her company, but only one, very clear reason why they would buy. Many empirical studies have demonstrated the valuable potential of this tactic if shareholders understand what to do (learn more here).

Consequently, let’s take a peek at the latest action regarding Array Biopharma Inc (NASDAQ:ARRY).

What does the smart money think about Array Biopharma Inc (NASDAQ:ARRY)?

At year’s end, a total of 15 of the hedge funds we track were bullish in this stock, a change of -25% from one quarter earlier. With hedgies’ capital changing hands, there exists a few key hedge fund managers who were increasing their holdings substantially.

According to our comprehensive database, Deerfield Management, managed by James E. Flynn, holds the largest position in Array Biopharma Inc (NASDAQ:ARRY). Deerfield Management has a $42 million position in the stock, comprising 2.3% of its 13F portfolio. On Deerfield Management’s heels is Samuel Isaly of OrbiMed Advisors, with a $16 million position; the fund has 0.5% of its 13F portfolio invested in the stock. Other hedge funds that are bullish include Daniel Gold’s QVT Financial, Thomas E. Claugus’s GMT Capital and Julian Baker and Felix Baker’s Baker Bros. Advisors.

Judging by the fact that Array Biopharma Inc (NASDAQ:ARRY) has experienced a declination in interest from hedge fund managers, it’s safe to say that there lies a certain “tier” of hedgies that decided to sell off their positions entirely at the end of the year. Interestingly, Wayne Holman’s Ridgeback Capital Management dumped the largest position of all the hedgies we track, totaling close to $11 million in stock.. JΘr⌠me Pfund and Michael Sj÷str÷m’s fund, Sectoral Asset Management, also dumped its stock, about $9 million worth. These bearish behaviors are important to note, as aggregate hedge fund interest dropped by 5 funds at the end of the year.

Insider trading activity in Array Biopharma Inc (NASDAQ:ARRY)

Insider buying is at its handiest when the company in question has experienced transactions within the past six months. Over the last half-year time period, Array Biopharma Inc (NASDAQ:ARRY) has seen zero unique insiders purchasing, and 1 insider sales (see the details of insider trades here).

With the results demonstrated by the aforementioned strategies, everyday investors should always pay attention to hedge fund and insider trading activity, and Array Biopharma Inc (NASDAQ:ARRY) shareholders fit into this picture quite nicely.

Click here to learn more about Insider Monkey’s Hedge Fund Newsletter

Insider Monkey’s small-cap strategy returned 29.2% between September 2012 and February 2013 versus 8.7% for the S&P 500 index. Try it now by clicking the link above.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Click here to Read Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 74 percentage points in 2.5 years. Our beta is only 1.2 (download a FREE newsletter and see the details inside)

Lists

Best Selling Magazines in the World

Shortest People in History

The Most Celebrated Holidays in the World

Most Expensive Handbag Brands in the World

Top Selling Comic Book Issues of this Century

The Most Powerful Women in Politics

Best Paid DJs

Most Rebellious Female Artists

Best Paid TV Actresses of 2014

Best Paid Actors of 2014

Most Expensive Horses in the World

Tallest People Ever

Most Encouraging Feminist Celebrities

Best Paid Supermodels of 2014

Top 10 Suburbs for Retirement in 2015

10 Wealthiest Cities in America

Top 10 TED Talks for Entrepreneurs

Best TED Talks on Education

25 Most Dangerous Places to Live in America

Top 10 Ski Resorts in the United States – 2014 List

Top 10 Most Remote Places in the World

Most Visited Museums in the United States

Wealthiest Photographers in the World

Most Famous Gay Athletes

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!